成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
TargetMol Chemicals Inc. Company Information
Company Name:
TargetMol Chemicals Inc.
Tel:
+1-781-999-5354
Email:
marketing@targetmol.com
Nationality:
United States
WebSite:
https://www.targetmol.com/
Product List:
32080
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
Product List
CB2R-IN-1
1257555-79-5
(+)-CBI-CDPI1
128300-14-1
(+)-CBI-CDPI2
128300-15-2
Cefmetazole sodium
56796-39-5
CBB1007
1379573-92-8
CBB1003
1379573-88-2
CBP/p300-IN-2;CBP/EP300-IN-2
2158265-96-2
CCG 203769
410074-60-1
CCI-006
292053-42-0
CCB02
2100864-57-9
Mezigdomide
2259648-80-9
Casopitant mesylate;GW679769B
414910-30-8
Numidargistat;INCB01158;CB-1158
2095732-06-0
CB1151
182369-28-4
CB-6644
2316817-88-4
Cav 2.2 blocker 1
1567335-29-8
Metoclopramide hydrochloride
7232-21-5
Cauloside D
12672-45-6
Casein Kinase II Inhibitor IV
863598-09-8
CAY10595
916047-16-0
CB1 inverse agonist 1
852315-00-5
CB2 modulator 1
666261-80-9
Calhex 231 hydrochloride
2387505-78-2
Canagliflozin-d4;Canagliflozin D4
1997338-61-0
Calmidazolium chloride
57265-65-3
Camalexin
135531-86-1
Carvedilol metabolite 4-Hydroxyphenyl Carvedilol;4-Hydroxyphenyl Carvedilol;4-Hydroxycarvedilol
142227-49-4
Carbacyclin;Carbaprostacyclin;Carba-PGI2
69552-46-1
Potassium Channel Activator 1
908608-06-0
MEK-IN-1
870600-45-6
Carbodine
71184-20-8
Carpaine
3463-92-1
Carpaine hydrochloride
5853-21-4
Carbodenafil
944241-52-5
Carboxypeptidase G2 (CPG2) Inhibitor
192203-60-4
Carmoxirole hydrochloride
115092-85-8
Carebastine
90729-42-3
Dithranol
1143-38-0
Capzimin
2084868-04-0
Carcainium chloride
1042-42-8
CARM1-IN-1
1020399-49-8
Candesartan-d4;CV-11974 D4;Candesartan D4
1346604-70-3
Candoxatril
123122-55-4
Amphotericin B
1397-89-3
5α-reductase-IN-1
119348-12-8
Butin
21913-99-5
C-021 dihydrochloride
1784252-84-1
BuChE-IN-TM-10
2313524-95-5
BY27
2247236-59-3
Ticarcillin disodium
4697-14-7
Btk inhibitor 2
1558036-85-3
C-82
1422253-37-9
Bucindolol
71119-11-4
Bunaftide
32421-46-8
Norepinephrine bitartrate monohydrate
108341-18-0
c-di-AMP;Cyclic diadenylate;Cyclic-di-AMP
54447-84-6
c-Fms-IN-10
1527517-50-5
c-Fms-IN-6
1628574-81-1
c-Fms-IN-7
1313408-89-7
c-Fms-IN-8
1255303-58-2
Bucolome;Paramidin;Paramidine
841-73-6
C-11
2007965-97-9
BTK inhibitor 13
2376726-26-8
BTK inhibitor 10
2241732-30-7
(Rac)-IBT6A
1412418-47-3
Bromelain
9001-00-7
Broflanilide
1207727-04-5
Baclofen
1134-47-0
Burixafor hydrobromide;TG-0054 hydrobromide
1191450-19-7
Bumetanide-d5;Bumetanide D5
1216739-35-3
IBT6A
1022150-12-4
BT-13
924537-98-4
Bromodomain IN-1
1914120-48-1
Bromodomain inhibitor-8
1300031-70-2
Capsaicin;8-Methyl-N-vanillyl-trans-6-nonenamide;Qutenza;Zostrix;(E)-Capsaicin;Vanilloid
404-86-4
IBT6A hydrochloride
1553977-42-6
BSc5371
2286419-03-0
c-Fms-IN-3
885704-21-2
c-Fms-IN-1
885703-64-0
c-Fms-IN-9
1628574-50-4
trans-C75;(±)-C75
191282-48-1
c-Met inhibitor 1
1357072-61-7
C75
218137-86-1
c-Kit-IN-2
2121515-37-3
c-Kit-IN-3
2363169-01-9
Vimseltinib
1628606-05-2
c-Met-IN-2
1635406-73-3
c-met-IN-1
2084836-84-8
CA inhibitor 1;GS-6207 analog
2189684-45-3
CAL-130
1431697-74-3
Calcimycin hemicalcium salt;A-23187 hemicalcium salt;Antibiotic A-23187 hemicalcium salt
59450-89-4
Ca2+ channel agonist 1
1402821-24-2
Calcimycin
52665-69-7
Calcium 2-oxoglutarate
71686-01-6
Ketanserin
74050-98-9
Calcium-Sensing Receptor Antagonists I
478963-79-0
Calcifediol-D6
78782-98-6
Calcitriol-d6;Calcitriol D6
78782-99-7
CAL-130 Racemate
474012-90-3
CAL-130 Hydrochloride
1431697-78-7
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
Copyright 2007© ChemicalBook. All rights reserved.